ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL
9
ꢁ
in a 10 mL flask at room temperature. The temperature was then raised to 110 C and
maintained for the appropriate time (see Table 2) with stirring. The reaction progress
was monitored by TLC (n-hexane:ethyl acetate, 2:1). After completion of the reaction
2 mL hot ethanol was added to the reaction mixture, and stirring was continued for
2 minutes. The Fe3O4@SiO2@PAMAM(G2)-SO3H catalyst was separatedꢁusing an exter-
nal magnet, then washed with ethanol and acetone, and dried at 60 C for 3 h. The
resulting mixture was poured into crushed ice, and the final products (6a-h and 7a-f)
were obtained through filtration and recrystallization from ethanol. All of the products
of this study were known compounds, identified by matching their melting points with
the literature values in the references cited in Table 2. Representative spectroscopic data
are given below for 6b and 7a.
Larger Scale Preparation of 6a
Fe3O4@SiO2@PAMAM(G2)-SO3H (2.5 g) was added to a mixture of benzaldehyde
(50 mmol, 5.3 g,), ethyl acetoacetate (60 mmol, 9.36 g), ammonium acetate (250 mmol,
19.25 g), and dimedone (50 mmol, 7.00 g) in a 100 mL flask at room temperature. The
ꢁ
temperature was then raised to 110 C and maintained for 20 min with stirring. The
reaction progress was monitored by TLC (n-hexane:ethyl acetate, 2:1). After completion
of the reaction 40 mL hot ethanol was added to the reaction mixture, and stirring was
continued for 5 minutes. The nanomagnetic catalyst was separated from the reaction
mixture as described above and the product isolated as described above and recrystal-
lized from 96% ethanol (80 ml) to afford 88% of ethyl-1,4,7,8-tetrahydro-2,7,7-trimethyl-
4-(phenyl)5-(6H)-oxoquinoline-3-carboxylate (6a).
Ethyl-1,4,7,8-tetrahydro-2,7,7-trimethyl-4-(4-chlorophenyl)5-(6H)-oxoquinoline-3-
carboxylate (6b)
IR (KBr, disc, cmꢂ1): 3275, 3194, 3080, 2967, 1710, 1644, 1610, 1490, 1394, 1280, 790;
1H-NMR (300 MHz, DMSO-d6): d 0.94 (s, 3H), 1.06 (s, 3H), 1.19 (t, J ¼ 7.1 Hz, 3H),
2.14–2.36 (m, 4H), 2.36 (s, 3H), 4.07 (q, J ¼ 7.1 Hz, 2H), 5.04 (s, 1H), 6.12 (brs, 1H,
NH), 7.16 (d, J ¼ 8.4 Hz, 2H), 7.26 (d, J ¼ 8.4 Hz, 2H); 13C-NMR (75 MHz, DMSO-d6):
d 14.21, 19.46, 27.11, 29.43, 32.72, 36.21, 41.10, 50.66, 59.92, 105.76, 111.90, 128.00,
129.45, 131.6, 143.61, 145.56, 148.12, 167.22, 195.50.
2-Methyl-4-phenyl-5-oxo-4,5-dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic acid
ethyl ester (7a)
IR (KBr, disk, cmꢂ1): 3252, 2960, 1702, 1664, 1552, 1390, 1210, 780; 1H-NMR
(300 MHz, DMSO-d6) d 1.11 (t, 3H), 2.42 (s, 3H), 4.05 (q, 2H), 4.75 (s, 1H), 6.88 (s,
1H, NH), 7.14–7.30 (m, 5H), 7.42–7.66 (m, 4H); 13C-NMR (75 MHz, DMSO-d6) d
14.01, 18.13, 35.94, 51.02, 105.15, 109.07, 118.02, 121.34, 127.87, 129.09, 130.36, 131.04,
132.76, 133.62, 136.21, 144.77, 145.63, 154.08, 168.21, 191.53.